Novartis Pays $422.5 Million in Settlement
By DUFF WILSON
The Swiss drug giant Novartis has agreed to pay $422.5 million to settle criminal and civil investigations into the marketing of the antiseizure medicine Trileptal and five other drugs, officials said on Thursday.

